Healthcare communications network serving oncology and hematology brands
Vaniam Group operates a distributed network of medical communications agencies focused on oncology and hematology, built on a fully virtual operating model since 2007. The hiring surge in sales (13 open roles) coupled with active projects around subscription models, AI integration, and third-party insights signals a shift from traditional project work toward recurring revenue and productized services. Pain points around audience generation and scaling operations suggest the network is moving beyond pure communications consulting into owned data and service offerings.
Notable leadership hires: Director, Executive Director
Vaniam Group is an independent network of healthcare and scientific communications agencies serving biotech and pharmaceutical companies. The group operates across multiple specialized brands (Bio Linx, Bio Connections, Nexus, Team 9, Second City Insights, CurioScience, and others) and partners with clients' commercial, medical, and clinical teams on oncology and hematology initiatives. The company is structured as a 100% virtual-by-design organization with 201–500 employees based in the United States and India. As a WBENC-Certified Women's Business Enterprise, Vaniam Group was founded in 2007 and operates from Chicago, Illinois.
Vaniam Group operates a network of healthcare communications agencies serving biotech and pharmaceutical clients in oncology and hematology. Services include medical communications, publication management, expert engagement, and clinical consulting across multiple branded agencies.
Vaniam Group is actively hiring in the United States and India, reflecting the company's distributed, virtual-first operating model.
Other companies in the same industry, closest in size